Extended results of the Alzheimer's disease anti-inflammatory prevention trial. [electronic resource]
Producer: 20111123Description: 402-11 p. digitalISSN:- 1552-5279
- Aged
- Aged, 80 and over
- Alzheimer Disease -- cerebrospinal fluid
- Amyloid beta-Peptides -- cerebrospinal fluid
- Anti-Inflammatory Agents, Non-Steroidal -- therapeutic use
- Celecoxib
- Confidence Intervals
- Double-Blind Method
- Female
- Humans
- Longitudinal Studies
- Male
- Naproxen -- therapeutic use
- Neuropsychological Tests
- Peptide Fragments -- cerebrospinal fluid
- Proportional Hazards Models
- Psychiatric Status Rating Scales
- Pyrazoles -- therapeutic use
- Sulfonamides -- therapeutic use
- tau Proteins -- cerebrospinal fluid
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
There are no comments on this title.
Log in to your account to post a comment.